Left Ventricular Dysfunction Following Myocardial Infarction

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2007-08-03
FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved Waylis Therapeutics LLC's supplemental application for COREG CR, the extended-release formulation of carvedilol phosphate.